In this issue:
- Non-invasive disease severity index for IBD
- Liraglutide for ileal pouch-anal anastomosis and chronic high bowel frequency
- Thiopurine therapeutic drug monitoring
- Pregnancy and stomas
- Optimising triage of urgent referrals for suspected IBD
- Serum infliximab concentrations associated with deep remission
- Subcutaneous infliximab biosimilar as maintenance therapy for IBD
- Long-term outcomes after early ileal resection for CD
- Need for therapeutic escalation in refractory ulcerative proctitis
- Science blog: tumour necrosis factor-like ligand 1A inhibition in IBD
Please login below to download this issue (PDF)